The impact of post-pulmonary embolism syndrome and its possible determinants.

Thromb Res

Department of Medicine, Østfold Hospital Trust, Sarpsborg, Norway; Department of Haematology, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Published: November 2018

Introduction: Recent studies suggest that up to 50% of patients surviving pulmonary embolism (PE) may suffer from post-PE syndrome, which is defined by persistent dyspnea, impaired exercise capacity and/or decreased health-related quality of life (HRQoL). The possible determinants of post-PE syndrome are however not fully established.

Aims: To describe the differences between dyspneic and non-dyspneic PE-patients and to explore determinants of dyspnea, 6-min walking test (6MWT) and HRQoL.

Material And Methods: In this cross-sectional study, consecutive patients diagnosed with PE between 2002 and 2011 at Østfold Hospital, Norway were identified from hospital registries. Patients were scheduled for clinical examination and a 6MWT. Dyspnea was assessed by the New York Heart Association (NYHA) classification. HRQoL was assessed with PEmb-QoL questionnaire. PE severity was assessed with PESI score, mean bilateral proximal extent of the clot and right-/left ventricle-ratio (RV/LV-ratio).

Results: 203 patients participated in this study, of which 96 patients reported dyspnea (47%). Median time from diagnosis was 3.6 years (IQR 1.9-6.5). Patients without dyspnea performed better on 6MWT (488 m vs 413 m, p < 0.005) and had better HRQoL results (p < 0.005). None of the variables we examined, including Charlson comorbidity index, was independently associated with dyspnea. However, higher RV/LV ratio at diagnosis was significantly associated with reduced 6MWT at follow-up. Further, ongoing anticoagulation and unemployment were independently associated with impaired HRQoL.

Conclusions: PE-survivors complaining of dyspnea suffer from impaired HRQoL and reduced exercise capacity. Although PE-severity factors were associated with reduced exercise capacity, none of the examined factors were found to be independent determinants of dyspnea.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.thromres.2018.09.048DOI Listing

Publication Analysis

Top Keywords

post-pe syndrome
8
patients
6
dyspnea
5
impact post-pulmonary
4
post-pulmonary embolism
4
embolism syndrome
4
syndrome determinants
4
determinants introduction
4
introduction studies
4
studies 50%
4

Similar Publications

Background: Half of people post pulmonary embolism (PE) experience ongoing symptoms such as dyspnoea, anxiety and depression, exercise limitation and fatigue. These symptoms can reduce their quality of life (QoL), psychological wellbeing, and functional capacity. The efficacy of rehabilitation interventions to prevent and manage these symptoms has not been established.

View Article and Find Full Text PDF

Pulmonary embolism (PE) is the third most frequent cause of acute cardiovascular presentation after myocardial infarction and stroke. The treatment approach for PE consists of hemodynamic and respiratory support, anticoagulation, reperfusion treatment, and vena cava filters. Reperfusion treatment consists of systemic thrombolysis (recombinant tissue-type plasminogen activator, streptokinase, and urokinase); percutaneous catheter-directed therapy (CDT); and surgical embolectomy.

View Article and Find Full Text PDF

Cardiopulmonary Exercise Testing, Rehabilitation, and Exercise Training in Postpulmonary Embolism.

Heart Fail Clin

January 2025

Division of Cardiology, Department of Medicine, University of Wisconsin-Madison, Hospitals and Clinics, 600 Highland Avenue CSC-E5/582B, Madison, WI 53792, USA. Electronic address:

Long-term exercise intolerance and functional limitations are common after an episode of acute pulmonary embolism (PE), despite 3 to 6 months of anticoagulation. These persistent symptoms are reported in more than half of the patients with acute PE and are referred as "post-PE syndrome." Although these functional limitations can occur from persistent pulmonary vascular occlusion or pulmonary vascular remodeling, significant deconditioning can be a major contributing factor.

View Article and Find Full Text PDF

Post-Pulmonary Embolism Syndrome-A Diagnostic Dilemma and Challenging Management.

Mayo Clin Proc

December 2024

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN. Electronic address:

Historically, research on pulmonary embolism (PE) management has focused on short-term outcomes, such as acute cardiovascular collapse, change in right ventricular function, and in-hospital mortality. However, long-standing functional impairments from acute PE occur in up to half of all patients. This chronic syndrome has been termed the post-PE syndrome, which describes patients who have persistent or worsening symptoms, functional limitations, and cardiorespiratory impairment not explained by a comorbid condition.

View Article and Find Full Text PDF
Article Synopsis
  • - Recent studies highlight a significant health issue known as "post-PE syndrome" (PPES) in patients who survived pulmonary embolism (PE), with cardiopulmonary exercise testing (CPET) being useful for evaluating these individuals.
  • - A systematic review analyzed 14 studies involving 804 post-PE patients to assess their exercise capacity and ventilatory efficiency through CPET data collected before August 2023.
  • - Findings revealed no major differences in exercise capacity between patients assessed less than six months versus six months or more after PE; however, those evaluated later showed significantly better ventilatory efficiency.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!